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ABSTRACT: Antimycins are a family of natural products
possessing outstanding biological activities and unique
structures, which have intrigued chemists for over a half
century. Of particular interest are the ring-expanded antimycins
that show promising anticancer potential and whose biosyn-
thesis remains uncharacterized. Speciﬁcally, neoantimycin and
its analogs have been shown to be eﬀective regulators of the
oncogenic proteins GRP78/BiP and K-Ras. The neoantimycin
structural skeleton is built on a 15-membered tetralactone ring
containing one methyl, one hydroxy, one benzyl, and three
alkyl moieties, as well as an amide linkage to a conserved 3-
formamidosalicylic acid moiety. Although the biosynthetic gene
cluster for neoantimycins was recently identiﬁed, the enzymatic
logic that governs the synthesis of neoantimycins has not yet
been revealed. In this work, the neoantimycin gene cluster is identiﬁed, and an updated sequence and annotation is provided
delineating a nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) hybrid scaﬀold. Using cosmid expression and
CRISPR/Cas-based genome editing, several heterologous expression strains for neoantimycin production are constructed in two
separate Streptomyces species. A combination of in vivo and in vitro analysis is further used to completely characterize the
biosynthesis of neoantimycins including the megasynthases and trans-acting domains. This work establishes a set of highly
tractable hosts for producing and engineering neoantimycins and their C11 oxidized analogs, paving the way for neoantimycin-
based drug discovery and development.
Antimycin (ant)-type depsipeptides are a large family ofnatural products widely produced by ﬁlamentous Actino-
bacteria.1,2 Antimycins are the archetypal members of this
family and have been known for almost 70 years.3 They possess
potent cytotoxicity because they bind to and inhibit
mitochondrial cytochrome c reductase, the terminal step in
respiration;4 this bioactivity is linked to a conserved 3-
formamidosalicylate moiety not observed elsewhere in nature.
Antimycin is used commercially as a piscicide and is the active
ingredient in Fintrol. Recently, antimycins were identiﬁed as
inhibitors of the Bcl-2/Bcl-XL-related antiapoptotic proteins
that are overproduced by cancer cells and confer resistance to
chemotherapeutic agents whose mode of action is activation of
apoptosis; it was also established that this antagonism is
independent of its respiratory inhibitory activity.5
More than 40 naturally occurring derivatives of antimycin
(nine-memberd ring) have been observed, and so-called “ring-
expanded” members of the family have also been described.1
These include JBIR-06 (12-membered ring),6 neoantimycin
(15-membered ring),7 and respirantin (18-membered ring).8
The hybrid nonribosomal peptide synthetase (NRPS)/
polyketide synthase (PKS) pathway dictating the biosynthesis
of antimycins was identiﬁed recently,9 which facilitated the
subsequent identiﬁcation of biosynthetic gene clusters (BGCs)
for ring-expanded members of the family.10,11 The biosynthesis
of all ant-type depsipeptides is directed by a hybrid NRPS/PKS
pathway that utilizes a 3-formamidosalicylate starter unit,
followed by L-threonine, various α-keto acids, and malonate
derivatives to produce a linear depsipeptide, which is cyclized
and released from the terminal module by a cis-acting
thioesterase domain. The ﬁnal cyclic depsipeptide is a
macrocyclic ring varying in size depending on the number of
NRPS modules, with each ring-expanded member of the family
possessing one additional module.10
Neoantimycins (compounds 1−6; Figure 1) are of particular
interest, because a C11 oxidized derivative of 3 named
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prunustatin A downregulates the expression of the major
molecular chaperone GRP78/BiP, whose overproduction is
required for cancer cell survival during hypoxic conditions
caused by their rapid proliferation.12 Additionally, several
neoantimycin derivatives displayed nanomolar potency in
causing the mislocalization of oncogenic K-Ras, a GTPase
that regulates cell growth and proliferation in numerous
cancers.13,14 Thus, neoantimycin is an exciting anticancer lead
compound for the treatment of diverse cancers. Natural
product lead compounds are diﬃcult to derivatize synthetically,
and a powerful alternative approach to this is bioengineering.
We therefore sought to robustly characterize the biosynthesis of
neoantimycin as the ﬁrst step toward establishing a platform for
biologically expanding the chemical space of this compound
class.
Figure 1. Biosynthesis of neoantimycins. (A) The neoantimycin biosynthetic gene cluster BGC in Streptomyces orinoci NRRL B-3379. The locations
of Cosmid 69 and 813 are indicated by horizontal lines, and a double vertical hash indicates that the cosmid insert harbors additional DNA that falls
outside the boundaries of this schematic. (B) The proposed biosynthetic pathway for neoantimycins. Structural variation arises from natural
promiscuity of NRPS modules 3 and 6 as well as formylation of the starter unit. A, adenylation; T, thiolation; C, condensation; KR, ketoreductase;
KS, ketosynthase; AT, acyltransferase; MT, methyltransferase; ACP, acyl-carrier protein; TE, thioesterase.
Table 1. Proposed Functions of Proteins Encoded by the Neoantimycin Biosynthetic Gene Cluster
gene
size,
aa deduced role protein homologuea accession number
identity/similarity
%/%
NatA 149 extracytoplasmic function RNA polymerase sigma
factor
AntA (S. blastmyceticus) AGG37762.1 83/93
NatB 4542 trimodular nonribosomal peptide synthetase AntC (S. blastmyceticus) AGG37764.1 68/76
NatC 1411 unimodular polyketide synthase hypothetical (S. albus sp. albus) KUJ65684.1 75/82
NatD 2403 unimodular nonribosomal peptide synthetase putative peptide synthetase (S.
pyridomyceticus)
AEF33080.1 44/55
NatE 66 MbtH-like protein MbtH family protein (S. solWspMP-5a-2) SCD38000.1 69/78
NatF 342 ketoreductase NAD-dependent epimerase (N. cosensis) WP033408890.1 54/65
NatG 255 thioesterase hypothetical (S. caatingaensis) WP049714988.1 69/78
NatQ 230 phosphopantetheinyl transferase EntD (Streptomyces sp. TLI 146) PKV83804.1 59/66
NatF′ 495 Acyl-CoA ligase CoA ligase (Streptomyces sp. ADM21) AIF33754.1 81/88
NatG′ 79 peptidyl carrier protein AntG (S. blastmyceticus) AGG37769.1 96/96
NatH 339 multicomponent oxygenase PaaG (S. albus sp. J1074) AG192189.1 84/91
Natl 97 multicomponent oxygenase anti (S. blastmyceticus) AGG37771.1 82/91
NatT 251 multicomponent oxygenase Paal (S. lincolnensis) WP067444180.1 72/80
NatK 165 multicomponent oxygenase PaaJ (Streptomyces sp. ERV7) OAR24946.1 81/89
NatL 366 multicomponent oxygenase AntL (S. blastmyceticus) AGG37774.1 74/82
NatN 270 tryptophan 2,3-dioxygenase AntN (S. blastmyceticus) AGG37776.1 79/87
NatO 274 N-formylase alpha/beta hydrolase (streptomyces sp.
ERV7)
WP067162889.1 81/86
NatP 416 kynureninase AntP (S. blastmyceticus) AGG37778.1 80/87
aResults generated by BLASTP analysis.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.8b00298
ACS Chem. Biol. 2018, 13, 1398−1406
1399
Here, we report the identiﬁcation, cloning, and heterologous
expression of the neoantimycin biosynthetic gene cluster from
Streptomyces orinoci NRRL B-3379. We use our heterologous
expression platform to establish the functionality of a trans-
acting ketoreductase, NatF, and type II thioesterase, NatG, and
combined with in vitro analyses, we also demonstrate that the
geminal dimethyl moiety originates from an iteratively and cis-
acting methyltransferase domain within the NatC PKS. On the
basis of our analyses, a biosynthetic pathway for neoantimycins
is proposed and in the longer term our genetically tractable
neoantimycin production platform can be used to facilitate the
rapid generation of novel neoantimycin analogs.
■ RESULTS AND DISCUSSION
Identiﬁcation of the Neoantimycin (nat) Biosynthetic
Gene Cluster. The nat BGC was previously identiﬁed in the
genome of S. orinoci NRRL B-3379; however, neither its DNA
sequence nor the genome sequence was made publically
available.11 The reported nat BGC and proposed biosynthetic
pathway deviated considerably from what is known about the
production of the related compound, antimycin. Two proteins
essential for the biosynthesis of the starter unit 3-
formamidosalicylate were missing: an orthologue of AntG, a
discrete peptidyl carrier protein (PCP), and an orthologue of
AntI, a constituent of the multicomponent oxygenase that
converts tryptophan to 3-aminosalicylate prior to N-formylation
by AntO.15,16 In addition, in the reported nat BGC, there was a
redundancy of ketoreductase (KR) domains encoded by both a
standalone gene (natF) and in the unimodular PKS gene
(natC) and a redundancy of thioesterase domains encoded by
both a standalone gene (natG) and in the NRPS gene (natE).
The sixth module encoded by the NRPS genes (natD and
natE) further showed abnormities that this module lacked a
typical condensation domain and the protein itself was
disconnected such that the adenylation domain encoding
gene would be divergently transcribed from the opposite strand
of DNA (Figure S1).
The above peculiarities prompted us to resequence S. orinoci
NRRL B-3379. The ﬁnal genome assembly, which is available
under GenBank accession PHNC01000000, revealed a
7,502,208 bp chromosome represented over 44 contigs. The
nat BGC was identiﬁed by the genome mining package
antiSMASH 3.0,17 whose identity was easily corroborated by
manual identiﬁcation of gene products orthologous to
AntFGHIJKLNO from S. albus,9,18,19 which biosynthesize the
3-formamidosalicylate moiety15,16,20 present in both antimycins
and compounds 1−3.
The ∼38 kb nat BGC identiﬁed in this study harbors 18
genes with the deduced functionalities shown in Table 1 and is
organized into four apparent transcriptional units (Figure 1).
Interestingly, we identiﬁed three previously unreported genes:
natE, natQ, and natI, which encode an MbtH-like protein, a
phosphopantetheinyl transferase, and the missing constituent of
the multicomponent oxygenase involved in 3-formamidosalicy-
late biosynthesis, respectively (Table 1, Figure 1). In addition,
we were unable to identify a KR domain within the deduced
amino acid sequence for NatC and, strikingly, identiﬁed the
gene encoding the NatD NRPS as a contiguous unbroken
coding sequence that harbored the anticipated condensation
domain (Figures 1 and S1). While it is formally possible that
the diﬀerences between our nat BGC and that reported
previously could result from genetic rearrangements and/or
deletions, it is more likely to be the consequence of incomplete
annotation and/or genome assembly error(s) considering the
previous study demonstrated the strain to produce neo-
antimycins.11
Veriﬁcation of Adenylation Domain Substrate Specif-
icity. To conﬁrm that the various alkyl substitutions on the
lactone ring are due to the promiscuity of the megasynthases,
we tested the adenylation domain substrate speciﬁcity of the
NatB and NatD NRPSs using an ATP/PPi exchange assay.
NatB was truncated into three individual modules, NatB-B, -C,
and -X, that contain biosynthetic modules 2, 3, and 4,
respectively, and were overproduced and puriﬁed from the E.
coli strain BAP1.21 Puriﬁed NatB-C showed activation of 3-
methyl-2-oxobutanoic acid, 3-methyl-2-oxopentanoic acid, and
pyruvate as expected by structural analysis of the naturally
occurring neoantimycins, and NatB-X exhibited a strong
activation of phenylpyruvate (Figure 2). Puriﬁed NatB-B
curiously did not exhibit PPi exchange activity when incubated
with its presumed substrate, L-threonine. However, the puriﬁed
dimodule protein NatB-BC was able to activate L-threonine as
well as 3-me-2-oxobutanoic acid, 3-me-2-oxopentanoic acid,
and pyruvate (Figure 2). This suggests that individual
Figure 2. Analysis of NRPS adenylation domain activity. The four NRPS adenylation domains within the neoantimycin biosynthetic gene cluster
were analyzed in vitro using ATP-[32P]PPi exchange assays to verify utilization of the predicted substrate for each module. Values are displayed as
relative activity normalized to 3-me-2-oxobutanoic acid (NatB-BC), 3-me-2-oxopentanoic acid (NatB-C), phenylpyruvate (NatB-X), and 3-me-2-
oxopentanoic acid (NatD) dependent exchange corresponding to approximately 250k cpm.
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truncation and puriﬁcation of module 2 did not yield an active
adenylation domain, albeit the protein seemed to be solubly
expressed from E. coli (Figure S2). The terminal module
harbored by NatD overproduced and puriﬁed as above and
exhibited PPi activity when incubated with the tested substrates
3-methyl-2-oxobutanoic acid and 3-methyl-2-oxopentanoic
acid. The demonstrated substrate speciﬁcities of four
adenylation domains are all consistent with the known
molecular structures of neoantimycins.
Cloning of the nat BGC and Heterologous Production
of Neoantimycins by Streptomyces coelicolor. S. orinoci is
genetically intractable, and therefore we pursued a heterologous
expression strategy in order to study neoantimycin biosynthesis.
We constructed a cosmid library and identiﬁed two overlapping
cosmids, Cosmid 69 and Cosmid 813, which together span the
entire nat BGC (Figure 1). In lieu of not capturing the entire
gene cluster in one cosmid, we modiﬁed Cosmid 69 and
Cosmid 813 to integrate into orthologous phage sites, which
would abrogate the need to establish a contiguous gene cluster
clone. Next, we replaced the native promoters of key loci in the
gene cluster with strong constitutive ones to ensure expression
of the gene cluster in a surrogate host (see Methods). In brief,
Cosmid 69 was engineered such that natFG was expressed from
the rpsL(XC) promoter (pRFSUL2), and Cosmid 813 was
engineered such that natBCDE was expressed from the
rpsL(XC) promoter and natA was expressed from the ermE*
promoter (pRFSUL3). On the basis of the promoter motifs
recognized by its characterized ortholog (σAntA), we predict that
σNatA will activate expression of natQF′G′HIJKLNOP.22
Engineered cosmids pRFSUL2 and pRFSRUL3 were mobilized
to S. coelicolor M1146,23 and chemical extracts prepared from
cointegrant and parental strains were evaluated by LC-HRMS
for the presence of neoantimycins. As we anticipated, molecular
formulas for neoantimycins such as 1−3 were only observed in
chemical extracts prepared from M1146 harboring both
pRFSUL2 and pRFSUL3, but not in extracts generated from
the empty M1146 strain (Figure S3). Taken together, these
data unambiguously establish the identity of the genes required
for the biosynthesis of neoantimycins.
Construction of a Chimeric Antimycin/Neoantimycin
Biosynthetic Pathway in Streptomyces albus. Although we
demonstrated eﬀective neoantimycin production using our
engineered cosmids and M1146, the strain does not sporulate
well, grows relatively slowly, and harbors several antibiotic
resistance markers, which limits the introduction of DNA in
future experiments. We therefore selected S. albus J1074 as a
heterologous production platform on the basis that it grows
rapidly and has genome editing tools such as the CRISPR/Cas9
system readily available.24 Since S. albus J1074 is a native
antimycin producer possessing the 3-formamidosalicylate
biosynthetic machinery, we subcloned natABCDE from Cosmid
813 into an E. coli-Streptomyces shuttle vector that additionally
had natFG cloned under a constitutive ermE* promoter. The
resulting plasmid containing natA-G was introduced into S.
albus J1074 by conjugative transfer to generate the strain 4c-1.
Analysis of the culture extracts of 4c-1 by LC-HRMS showed
the heterologous production of all six of the neoantimycins that
have previously been isolated from S. orinoci, and the titers of
these compounds were comparable to those from the native
producer (Figures 3 and S4). Successful combinatorial
heterologous production of neoantimycins encouraged the
creation of an unmarked heterologous host to facilitate future
engineering eﬀorts and remove background antimycin
production. We used CRISPR/Cas9 genome editing to create
an unmarked strain of S. albus J1074 (named 5c-1) in which
antC was replaced by natB, and ermE*p-driven natCDEFG was
introduced into the intergenic space between antE and antF
within the antimycin BGC (Figure 4). Chemical extracts
prepared from 5c-1 demonstrated its ability to produce
neoantimycins with a titer similar to that of the native producer
S. orinoci (Figure 3). These data demonstrate that the NatB
NRPS eﬃciently interacts with 3-formamidosalycilate-S-AntG
and is the ﬁrst experimental evidence suggesting combinatorial
bioengineering of ant-type depsipeptide biosynthesis may be
possible.
Interestingly, the strain 5c-1 would promote the formation of
a chimeric biosynthetic assembly line consisting of NatB and
AntD (Figure 4), which would result in the production of 12-
membered ring ant-type depsipeptides related to JBIR-06.6 We
therefore closely inspected LC-HRMS data sets generated with
the 5c-1 strain but were unable to detect molecular formulas
consistent with variants related to JBIR-06, suggesting that both
NatB and AntD do not interact to form a functional assembly
line, or a dedicated thioesterase is needed to cyclize and release
the 12-membered lactone ring. This conclusion is consistent
with the lack of 12-membered ring compounds from the
intermediate strains 5c-0, in which antC was replaced by natB
(Figure 4). In addition, the production of antimycins (nine-
membered ring) by 5c-0 and 5c-1 was not detected,
demonstrating the lack of interactions between NatB and
AntD for antimycin synthesis through module skipping.
The Geminal-Dimethyl Moiety of Neoantimycins Is
Generated by a cis-Acting Methyltransferase Domain
That Functions Iteratively. The placement of the geminal-
dimethyl moiety observed at C12 of neoantimycins implicates
involvement of the penultimate biosynthetic module encoded
by the NatC PKS (Figure 1). Bioinformatics analysis of the
NatC revealed the following domain composition, KS-AT-MT-
ACP; however, the substrate speciﬁcity of AT could not be
reliably predicted.25 Given the absence of other enzymes with
predicted methyltransferase activity within the nat BGC, we
hypothesized that the cis-acting MT domain generates the
geminal-dimethyl moiety either by acting once upon a
methylmalonate unit or twice upon a malonate unit. In order
Figure 3. Heterologous production of neoantimycins. Extracted ion
chromatograms show the production of neoantimycins by the wild-
type S. orinoci and two engineered S. albus strains. The calculated mass
with a 10 ppm error tolerance was used. Calculated masses: 1, m/z
699.3124 [M + H]+; 2, m/z 685.2967 [M + H]+; 3, m/z 671.2811 [M
+ H]+; 4, m/z 671.3180 [M + H]+; 5, m/z 657.3018 [M + H]+; 6, m/z
643.2861 [M + H]+.
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to distinguish between these possibilities, we overexpressed and
puriﬁed NatC using E. coli BAP1 and performed a 14C gel
autoradiography assay to determine if [2-14C]malonyl-CoA
could be loaded onto the PKS. The results of this assay showed
successful transfer of the radiolabel to NatC, indicating that the
NatC-AT domain was functional in vitro and capable of
recognizing malonyl-CoA (Figure 5A). As this did not exclude
the possibility that methylmalonyl-CoA could also be utilized,
we then fed [methyl-d3] L-methionine (the precursor of the
predicted methyl group donor, S-adenosylmethionine (SAM))
to 4c-1. In this experiment, a single methylation would result in
production of neoantimycins with molecular masses of M + 3,
whereas a dimethylation would produce molecular masses of M
+ 6. LC-UV analysis of the resultant chemical extracts showed
that the fermentation product proﬁles remained the same upon
the feeding of unlabeled and labeled L-methionine (Figure S5),
and LC-HRMS analysis showed the presence of M + 6
neoantimycins upon the feeding of [methyl-d3] L-methionine,
indicating a dimethylation event. We also observed M + 3
neoantimycins upon the feeding of labeled L-methionine, which
is most likely a consequence of incorporation of one labeled
and one unlabeled methyl group (Figure 5B).
To corroborate the above ﬁndings and to unambiguously
determine the malonyl-CoA utilized by NatC, we deactivated
NatC-MT in 5c-1 by using CRISPR/Cas9 genome editing to
replace a codon for a catalytically important histidine with
asparagine (H1189N).26 LC-HRMS analysis of chemical
extracts generated from the resulting mutant strain (named
7a-3) showed the absence of neoantimycins and the presence of
compounds with molecular masses consistent with a loss of the
Figure 4. Construction of strain 5c-1 using CRISPR/Cas9. The gene antC in the antimycin BGC of S. albus J1074 is replaced by natB to generate an
intermediate strain 5c-0, followed by the insertion of natCDEFG to generate 5c-1.
Figure 5. Characterization of NatC. (A) 14C gel autoradiography assay showing the labeling of NatC by [2-14C]malonyl-CoA. (B) Selected isotopic
peak patterns of neoantimycins produced by cultures fed with unlabeled L-methionine (top) and [methyl-d3] L-methionine (bottom). (C) Extracted
ion chromatograms showing the production of neoantimycins and des-geminal dimethyl neoantimycins by engineered S. albus strains. The calculated
mass with a 10 ppm error tolerance was used. Calculated masses: 1, m/z 699.3124 [M + H]+; 2, m/z 685.2967 [M + H]+; 3, m/z 671.2811 [M +
H]+; 7, m/z 671.2811 [M + H]+; 8, m/z 657.2654 [M + H]+; 9, m/z 643.2498 [M + H]+. The proposed structures of 7−9 are shown to the left.
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geminal dimethyl moiety (Figures 5C and S6). Subsequent
MS/MS analysis of these compounds in comparison to
neoantimycins was indicative of des-geminal dimethyl neo-
antimycins (Figures S7 and S8). Taken together, these data
indicate that NatC utilizes malonyl-CoA and NatC-MT acts
iteratively to generate the geminal dimethyl moiety.
NatG Is a Proofreading Thioesterase and NatF Is a
trans-Acting Ketoreductase. We next probed the “redun-
dant” gene products NatG and NatF encoded in the nat BGC
in comparison to the ant BGC. On the basis of our
reannotation of nat BGC, we propose that, similar to AntM,
NatF is likely a trans-acting ketoreductase that is responsible for
the apparent regiospeciﬁc ketoreduction at C11. Further
bioinformatics analysis of NatG shows that it belongs to
InterPro Family IPR01223, which indicates that NatG is likely a
proofreading or type II thioesterase. Many PKS and NRPS
biosynthetic gene clusters harbor a gene specifying a type II
thioesterase, where they have been shown to increase
production levels by removal of aberrant thioester intermedi-
ates from the assembly line.27 We chose to establish the
functionality of NatG and NatF in vivo and did so with our S.
albus-based neoantimycin production platform.
Two cosmids harboring either natABCDEF or natABCDEG
were constructed and mobilized to S. albus J1074 to generate
strains 4c-2 and 4c-3, respectively. Chemical extracts from the
resulting strains were analyzed by LC-UV and compared to the
extracts generated from S. albus J1074 harboring natABCDEFG.
Neoantimycins were still produced in the absence of natG albeit
at a reduced titer, which is consistent with our hypothesis that
NatG is a proofreading thioesterase (Figure 6). Conversely,
neoantimycins were not observed in chemical extracts
generated in the absence of natF; instead, a suite of compounds
with UV absorption spectra identical to those of neoantimycins,
but with shifted retention times, was observed (Figures 6 and
S9). LC-HRMS and MS/MS analysis of these compounds were
consistent with oxidized variants of neoantimycins, such as
prunustatin A and neoantimycin H that were reported
previously (Figures S10 and S11).13 The identity of o-3 was
further conﬁrmed by comparing to the authentic standard of
prunustatin A. These results indicate that NatF is responsible
for reduction of the keto group to a hydroxyl on C11. Since
oxidized neoantimycins have shown interesting biological
activities with prunustatin A established as a downregulator of
the molecular chaperone BiP/GRP78,12 this work has also
generated a useful strain that produces C11 oxidized neo-
antimycins exclusively.
Proposed Biosynthetic Pathway for Neoantimycins.
On the basis of the above in vivo and in vitro analysis, we
propose a complete neoantimycin biosynthetic pathway as
follows (Figure 1): it begins with the opening of the indole ring
of tryptophan by a tryptophan 2,3-dioxyngenase (NatN) to
produce N-formyl-L-kynurenine, which is converted to
anthranilate by a housekeeping N-formylase or NatO and a
kynureninase (NatP). Anthranilate is then activated by an acyl-
ACP ligase, NatF′, and loaded into its cognate carrier protein,
NatG′, followed by conversion to 3-aminosalicylate by a
multicomponent oxygenase NatHIJKL and N-formylation by
NatO. 3-Formamidosalicyl-S-NatG′ serves as a starting unit for
the hybrid NRPS/PKS machinery and is ﬁrst presented to the
NatB NRPS. NatB possesses three modules organized as
follows: C1-A1-T1-C2-A2-KR1-T2-C3-A3-KR2-T3. The A1
domain activates and loads L-Thr onto T1 followed by
condensation with 3-formamidosalicylate by C1 to form an
amide bond. The A2 domain activates and loads pyruvate, 3-
methyl-2-oxobutanoic acid, or 3-methyl-2-oxopentanoic acid
onto T2, which is subsequently stereospeciﬁcally reduced by
KR1 and condensed with L-Thr by C2. The A3 domain
activates and loads phenyl pyruvate onto T3, which is
stereospeciﬁcally reduced by KR2 and condensed with the
aminoacyl thioester attached to T2. The NatC PKS harbors one
module organized as follows: KS-AT-MT-ACP. AT transfers
malonate to ACP followed by installation of the geminal
dimethyl group by MT. Next, KS catalyzes decarboxylative
condensation between geminal dimethyl malonate and the
aminoacyl thioester on T3 of NatB. The NatD NRPS harbors
one module organized as follows: C4-A4-KR3-T4-TE. The A4
domain activates and loads 3-methyl-2-oxobutanoic acid or 3-
methyl-2-oxopentanoic acid onto T4, which is stereospeciﬁcally
reduced by KR3 and condensed with the aminoacyl thioester
attached to NatC-ACP prior to macrolactone cyclization and
release of the 15-membered ring by NatD-TE. The trans-acting
ketoreductase NatF reduces the C11 ketone to a hydroxyl, most
likely acting on an intermediate tethered to the assembly line.
In conclusion, our characterization and strain development
within this work pave the way for rational reprogramming of
the neoantimycin assembly line toward the biosynthesis of
neoantimycin analogs.
■ METHODS
Growth Media, Strains, and Reagents. Escherichia coli strains
were cultivated on Lennox agar (LA) or broth (LB), and Streptomyces
strains were propagated on mannitol-soya ﬂour agar or broth.28
Culture media were supplemented with antibiotics as required at the
Figure 6. Characterization of NatF and NatG. HPLC-UV analysis of
neoantimycins produced by engineered S. albus strains expressing
diﬀerent combinations of natF and natG. Chromatograms (320 nm)
show neoantimycin (1−3) production by S. albus 4c-1 expressing
natABCDEFG and reduced titers of neoantimycins by S. albus 4c-2
omitting natG that encodes a type II thioesterase. A new set of
neoantimcyin derivatives was produced by S. albus 4c-3 omitting natF
that encodes a ketoreductase.
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following concentrations: apramycin (50 μg/mL), carbenicillin (100
μg/mL), hygromycin (75 μg/mL), kanamycin (50 μg/mL), and
nalidixic acid (25 μg/mL). Chemicals and media were purchased from
Fisher Scientiﬁc or Sigma-Aldrich unless otherwise stated. Phusion
High-Fedelity PCR Master Mix (NEB) was used for PCR reactions.
Restriction and ligation enzymes were purchased from New England
Biolabs unless otherwise stated. Oligonucleotides were purchased from
Integrated DNA Technologies and are described in Table S1. The
DNA constructs and bacterial strains used in this study are listed in
Tables S2 and S3, respectively.
Genome Sequencing. S. orinoci NRRL B-3329 was obtained from
the United States Department of Agriculture ARS stock center. S.
orinoci chromosomal DNA was sequenced by the Earlham Institute
(Norwich, UK) using the Paciﬁc Biosciences and Illumina MiSeq
platforms. The hierarchical genome assembly process (HGAP) was
applied to two RSII SMRT cells worth of sequencing data, which
generated 44 contigs comprised of ∼7.5 Mb of DNA sequence. In
order to correct errors originating from PacBio sequencing, 14,938,895
250-bp paired-end Illumina reads were mapped to these contigs using
the Geneious R8.1.19 implementation of Bowtie2. The ﬁnal genome
assembly is available under DDBJ/EMBL/GenBank accession
PHNC01000000 and consists of 44 contigs comprised of 7,502,208
bp. The raw PacBio and Illumina reads are available under Short Read
Archive accessions SRR6318812 and SRR6318811, respectively.
Cosmid Library Construction and Screening. A Supercos1
cosmid library was constructed from S. orinoci NRRL B-3329 genomic
DNA partially digested with Sau3AI and packaged into Gigapack III
XL phage according to the manufacturer’s instructions (Agilent
Technologies). One thousand cosmid clones were screened for an
insert spanning the neoantimycin BGC by PCR using primers RFS468
and RFS469 (which target the 3′ end of natB and 5′ end of natC,
respectively) and RFS519 and RFS520 (which target natG; Table S1).
The resulting cosmids, Cosmid 69 and Cosmid 813, were insert-end
sequenced using primers RFS184 and RFS185 and mapped onto the S.
orinoci genome using BLAST 2.2.29+.29
Construction of pUC19-PAprP, pUC19-PHygP, and pRFSUL1.
The recombineering PCR templates PAprP and PHygP were
constructed as follows: (1) RFS406 and RFS407 were used to amplify
the apramycin resistance gene and oriT from pIJ77330 and the
hygromycin resistance gene and oriT from pIJ10700.31 (2) RFS658
and RFS659 were used to PCR amplify the rpsL(XC) promoter from
pCRISPomyces.24,32 (3) RFS667 and RFS668 were used to PCR
amplify the ermE* promoter from pSET152-ermEp,33 and (4) RFS663
and RFS664 were used to linearize pUC19. The resulting PCR
products were restricted with DpnI, gel puriﬁed, and assembled using
the NEB HiFi DNA Assembly kit. The resulting plasmids, pUC19-
PAprP and pUC19-PHygP, contained FRT site-ﬂanked apramycin and
hygromycin resistance genes, respectively, and divergently ﬁring
rpsL(XC) and ermE* promoters. The plasmid pRFSUL1 was
generated by RecET recombineering using E. coli strain GB05-red.34
Brieﬂy, oligonucleotides RFS448 and RFS449 were used to PCR
amplify a ∼2.2 kb fragment from pMS82, which contained the ΦBT1
integrase, attP, and a hygromycin resistance gene.35 Recombineering
with this PCR fragment replaced the neo/kan resistance gene present
on the backbone of Supercos1 to generate pRFSUL1. The ΦBT1
integrase, attP, and a hygromycin resistance gene is released from
pRFSUL1 by a SspI restriction digest and can be used to recombineer
Supercos1 clones of interest for integration into Streptomyces
chromosomes. The DNA sequences for pUC19-PAprP, pUC19-
PHygP, and pRFSUL1 are available at http://www.ryanseipkelab.
com/tools.html.
Cosmid Manipulations. Cosmid 69 and Cosmid 813 were
engineered to integrate into S. coelicolor chromosomes using RecET
recombineering with E. coli GB05-red and a ∼5.2 kb and 5.4 kb SspI
restriction fragment from pRFSUL1 and pIJ10702,36 respectively. The
resulting cosmids were named Cosmid 69-ΦBT1 and Cosmid 813-
ΦC31. RecET recombineering with pUC19-PAprP and oligonucleo-
tides DT133 and DT134 was used to modify Cosmid 69-ΦBT1 such
that it only harbored natFGQF′G′HIJKLNOP and that natFG
expression was driven by the rpsL(XC) promoter. The resulting
cosmid was named pRFSUL2. RecET recombineering with pUC19-
PHygP and oligonucleotides DT132 and DT135 was used to engineer
Cosmid 813-ΦC31 such that natA and natB were expressed from the
ermE* and rpsL(XC) promoters, respectively, to result in Cosmid813-
ΦC31-mod. The hygR gene of the PHygP cassette was removed from
Cosmid 813-ΦC31-mod by the Flp recombinase encoded by pCP20
as previously described30 to result in pRFSUL3.
Construction of Neoantimycin-Producing S. albus Strains. S.
orinoci genomic DNA was used as a template for PCR ampliﬁcation of
natF/G/FG; the resulting PCR product was cloned into pIB13937 by
Gibson assembly. The resulting plasmid was then ampliﬁed by PCR
and further cloned into the NsiI/CIP-digested cosmid 813 containing
natA−E using Gibson assembly. Subsequently, the constructs were
electroporated into E. coli WM6026 and used for conjugation with S.
albus J1074. Transconjugants were selected by apramycin and
kanamycin resistance and conﬁrmed by PCR using the natE-Duet-
F/Duet-Mbth-R primers. The resulting strains were 4c-1, 4c-2, and 4c-
3. To construct the CRISPR/Cas9 generated strain 5c-1, the
neoantimycin biosynthetic genes were introduced into the S. albus
J1074 chromosome using the recently described pCRISPomyces-2
system.24 Two pCRISPomyces-2 plasmids (pJL129 and pJL134) were
generated using Golden Gate and Gibson Assembly as previously
described.24 pJL129 was used to introduce natCDEFG under the
control of the ermE* promoter in between antE and antF. pJL134 was
used to replace antC from the antimycin BGC with natB. First, pJL134
was mobilized to S. albus J1074 by cross-genera conjugation as
previously described.28 Temperature sensitive pCRISPomyces-2
plasmid was removed from apramycin-resistant transconjugants by
culturing at 37 °C. Replacement of antC by natB in the correct locus
within the chromosome was veriﬁed by PCR and resulted in the
generation of a strain we named 5c-0: S. albus J1074 ΔantC::natB.
Next, pJL129 plasmid was mobilized to S. albus J1074 + PermE*
natCDEFG and processed as above in order to generate a strain we
named 5c-1: S. albus J1074 ΔantC::natB + PermE* natCDEFG. In
order to introduce the H1189N mutation, a third pCRISPomyces −2
plasmid, pDS,90 was created by adapting pJL129 to insert natCDEFG
with the mutant natC. To construct pDS90, pJL129 was digested with
EcoR321 and BseJI restriction enzymes, and the resulting 26.7 kb
linear plasmid was gel puriﬁed. A single base pair change in the MT
domain was introduced by overlap PCR from S. orinoci genomic DNA
us ing pJL129_EcoRV_F/H1189N_R and H1189N_F/
pJL129_BseJ1_R. A three-piece Gibson assembly was used to
introduce the overlapping PCR products to the digested pJL129
plasmid. The integrity of the resulting plasmid was veriﬁed by DNA
sequencing and subsequently used as above to generate S. albus J1074
ΔantC::natB + PermE* natCDEFG + natCMTH1189N, the methyl-
ation deﬁcient neoantimycin producer, named 7a-3.
Analysis of S. coelicolor Strains. Engineered cosmids pRFSUL2
and pRFSUL3 were mobilized to S. coelicolor M1146 by cross-genera
conjugation from E. coli ET12567/pUZ8002 as previously described.28
M1146 strains were cultured in 10 mL of LB while shaking (200 rpm)
at 30 °C for 3 days, at which point the entire culture was added to
mannitol-soya ﬂour broth (50 mL in a 250-mL ﬂask) and incubated at
30 °C while shaking (200 rpm). After 8 days of growth, bacterial cells
were removed by centrifugation, and all of the culture supernatant was
extracted once with two volumes of ethyl acetate and concentrated in
vacuo. The residue was resuspended in 0.3 mL of methanol (100%).
Two microliters of methanolic extract were injected into a Bruker
MaXis Impact TOF mass spectrometer equipped with a Dionex
Ultimate 3000 HPLC exactly as previously described.33
Analysis of S. albus Strains. S. albus strains were ﬁrst grown in a
2 mL of tryptic soy broth seed culture and inoculated at 1% inoculum
into a 25 mL mannitol-soya ﬂour broth. Cultures were grown for 5
days at 30 °C and 150 rpm. Mycelia were removed by centrifugation,
and the supernatant was extracted with two volumes of ethyl acetate
and dried with MgSO4 before rotary evaporation. Dried extracts were
resuspended in methanol and analyzed via LC-HRMS or LC-UV-MS.
LC-HRMS analysis was performed on an Agilent 6520 Accurate-Mass
Q-TOF LC-MS, and LC-UV-MS analysis was performed on an Agilent
6120 Single Quadrupole LC/MS with a 1260 series DAD. Each
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instrument was equipped with an Agilent Eclipse Plus C18 column
(4.6 × 100 mm), and in each case a linear gradient of 25−95%
CH3CN with 0.1% formic acid (v/v) over 20 min in H2O with 0.1%
formic acid (v/v) at a ﬂow rate of 0.5 mL/min was used. A culture
equivalent of 100 μL was injected. A collision energy of 20 V was used
for all HRMS/MS experiments.
Overproduction and Puriﬁcation of Recombinant Protein.
The NRPS components, NatB and NatD, and the PKS NatC were
cloned and puriﬁed as follows. NatD and NatC were PCR ampliﬁed
from S. orinoci genomic DNA as intact proteins. NatB was separated
into three individual modules and PCR ampliﬁed as NatB-B, NatB-C,
and NatB-X as well as a fourth construct containing the ﬁrst two
modules, NatB-BC from S. orinoci genomic DNA. Puriﬁed PCR
constructs were cloned into either pET-30 or pET-24b using Gibson
assembly or restriction enzyme digestion and quick ligation. Plasmids
were veriﬁed by sequencing and transformed into BAP1 cells for
protein production. Expression strains were grown in 0.7 L of LB
supplemented with 50 μg/mL of kanamycin at 37 °C and 250 rpm
until an OD600 of 0.5. Cultures were then put on ice for 10 min before
induction with 120 mM IPTG. Induction of gene expression lasted for
16 h at 16 °C and 200 rpm. The cells were then harvested by
centrifugation (6000 rpm, 15 min, 4 °C), and supernatant was
removed. The pellet was resuspended in 30 mL of lysis buﬀer (25 mM
HEPES, pH 8, 0.5 M NaCl, 5 mM imidazole) and homogenized using
an Avestin homogenizer. The insoluble fraction was removed by
centrifugation (15,000 rpm, 1 h, 4 °C), and the supernatant was
ﬁltered with a 0.45 μM ﬁlter before batch binding. Ni-NTA resin
(Qiagen) was added to the ﬁltrate at 2 mL/L of cell culture, and
samples were allowed to nutate for 1 h at 4 °C. The protein resin
mixture was added to a gravity ﬁlter column, and the ﬂow through was
discarded. The column was then washed with approximately 24 mL of
wash buﬀer (25 mM HEPES, 300 mM NaCl, pH 8) until untagged
proteins were removed, determined by Bradford assay. Tagged protein
was then eluted in approximately 18 mL of elution buﬀer (25 mM
HEPES, 100 mM NaCl, 250 mM imidazole, pH 8). Complete elution
was determined by Bradford assay. Puriﬁed proteins were then
concentrated and exchanged into appropriate buﬀer (25 mM HEPES,
100 mM NaCl, pH 8) using Amicon ultra ﬁlter units. After two rounds
of exchange and concentration, pure protein was removed, and
glycerol was added to a ﬁnal concentration of 8%. Proteins were stored
at −80 °C or used immediately for in vitro assays.
Isotope-Labeled Precursor Feeding Experiments. S. albus
J1074 4c-1 was cultured for the production of neoantimycins as
described above, and 24 h after inoculation of the seed culture into 25
mL of MS with apramycin (100 μg/mL) and kanamycin (100 μg/mL),
either unlabeled L-methionine or [methyl-d3] L-methionine was added
to cultures to a ﬁnal concentration of 1 g/L. Compound extraction and
LC-HRMS analysis were performed as described above.
14C Gel Autoradiography. Assays were performed in 10 μL of 50
mM HEPES (pH 8.0) containing 1 mM TCEP, 4 mM ATP, 4 mM
MgCl2, 1 mM CoA, 0.13 mM [2-
14C]malonic acid (0.1 mCi/mL;
American Radiolabeled Chemicals), 25 μM MatB (malonyl-CoA
synthetase), and 90 μM NatC. Reactions were incubated for 2 h at RT
and quenched with an equal volume of 1× SDS sample buﬀer before
SDS-PAGE analysis with a 4−15% TGX gel (Criterion). The gel was
subsequently dried for 2.5 h at 50 °C and then exposed on a storage
phosphor screen (20 × 25 cm; Molecular Dynamics) for 2−3 days.
Phosphor images were captured using a Typhoon 9400 phosphor-
imager (Storage Phosphor mode, best resolution, 50 μm resolution;
Amersham Biosciences).
ATP-PPi Exchange Assays. Substrate speciﬁcity assays were
performed in 100 μL of reaction buﬀer (50 mM Tris-HCl pH 8, 2 mM
MgCl2) containing 1 mM TCEP, 5 mM ATP, 1 mM tetrasodium
pyrophosphate (Na4PPi), 5 mM substrate, and 5 μM enzyme. Before
the addition of enzyme, Na4[
32P]-PPi was added to a ﬁnal intensity of
∼2.5 × 106 cpm/mL. Reactions were allowed to proceed for 2 h at 25
°C and then quenched by the addition of 500 μL of charcoal (3.6% w/
v activated charcoal, 150 mM Na4PPi, 5% HClO4). Samples were
centrifuged, and supernatant was discarded. To remove residual free
[32P]PPi, the pellet was washed twice with wash solution (0.1 M
Na4PPi, 5% HClO4). The pellet was resuspended in 500 μL of water
and added to scintillation ﬂuid at a ﬁnal volume of 5 mL. Radioactivity
was measured using a Beckman LS 6500 scintillation counter.
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